Owner Vascular Biogenics Ltd.

Inventors Harats, Dror; Bloom, Nira; Breitbart, Eyal

Agent Cullens

Pub. Number AU-B-2010202660

Parent 2003222427

Filing date 25 June 2010

Wipo publication date 15 July 2010

Acceptance publication date 18 August 2011

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 14/475 (2006.01) Peptides having more than 20 amino acids

C07K 14/515 (2006.01) Peptides having more than 20 amino acids

C07K 14/575 (2006.01) Peptides having more than 20 amino acids

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/85 (2006.01) Mutation or genetic engineering - for animal cells